1. Zhang, Weihao, Xie, Yongjie, Yu, Xin, Xing, Wenge, Si, Tongguo. 2023. ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer. In Discover oncology, 14, 87. doi:10.1007/s12672-023-00690-7. https://pubmed.ncbi.nlm.nih.gov/37273016/
2. Bian, Jing, Xiong, Wenji, Yang, Zhiguang, Zhang, Yanli, Liu, Chaoying. 2024. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma. In Scientific reports, 14, 522. doi:10.1038/s41598-024-51182-9. https://pubmed.ncbi.nlm.nih.gov/38177255/
3. Belnap, Conner, Divis, Tyler, Kingsley, Karl, Howard, Katherine M. 2024. Differential Expression of MicroRNA MiR-145 and MiR-155 Downstream Targets in Oral Cancers Exhibiting Limited Chemotherapy Resistance. In International journal of molecular sciences, 25, . doi:10.3390/ijms25042167. https://pubmed.ncbi.nlm.nih.gov/38396844/
4. Lin, David Tse Shen, Conibear, Elizabeth. 2015. ABHD17 proteins are novel protein depalmitoylases that regulate N-Ras palmitate turnover and subcellular localization. In eLife, 4, e11306. doi:10.7554/eLife.11306. https://pubmed.ncbi.nlm.nih.gov/26701913/
智鼠故事 
